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1 INTRODUCTION
Multiple Attribute Decision Making (MADM) involves “making preference decisions (such
as evaluation, prioritization, selection) over the available alternatives that are characterized by
multiple, usually conflicting, attributes” [9].  The problems of MADM are diverse, and can be
found in virtually any topic. Even Ben Franklin, over 200 years ago recognized the presence of
multiple attributes in everyday decisions, and suggested a workable solution [10].
In this paper, we use three different scoring methods for evaluating the performance of
different imaging techniques used to detect cancers in the female breast.
The need for such a decision support system arises from the fact that each of the several
techniques which helps diagnose breast cancer today, has its own specific characteristics,
advantages and drawbacks. These characteristics or attributes are generally conflicting.
The goal is to detect as many malignant lesions in the breast as is possible, while identifying
the maximum number of benign lesions.  The four imaging techniques that are compared here
are Magnetic Resonance Imaging (MRI), Mammography, Ultrasonography, and Nuclear
Medicine.
The three different multiattribute scoring methods are the Simple Additive Weighting
method (SAW), the Weighted Product Method (WPM), and the Technique for Order Preference
by Similarity to Ideal Solution (TOPSIS).
The three methods are described in detail, and then used to rank the four imaging techniques.
The results are analyzed and the validity and robustness of the methods are tested using post-
evaluation analysis.
2 CHOOSING THE RIGHT IMAGING TECHNIQUE FOR BREAST CANCER
DETECTION
The emphasis on early detection of breast cancer, the desire not to miss a malignant lesion in
the early stage of disease, and the current medicolegal environment encourage an aggressive
biopsy approach to breast problems [8].  With such an approach, a large majority of the palpable
and mammographically detected nonpalpable breast lesions on which biopsies are performed
will be benign [8]. Actually the positive biopsy rate for cancer is low (10%-31% [15][16][17]),
meaning that 70%-90% of breast biopsies are performed in women with benign disease [8].
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Biopsies, although well tolerated, involve some risk, induce patient discomfort and anxiety,
and increase costs in terms of both patient recovery and overall health care expenses [8]. Indeed,
according to Stavros and al. [8], the total cost for percutaneous large-core biopsy (including the
technical component, the physician’s fee, and the pathology fees) of a breast nodule with
ultrasound guidance is approximately $1000.  The total cost for an excisional breast biopsy is
between $3000 and $4500.
It is therefore imperative to choose the best imaging technology in order to reduce the
negative-to-positive biopsy ratio, and therefore the cost to society (including health care
expenses). The financial savings could be considerable. Furthermore, the morbidity associated
with the biopsy procedure including the lost time from work that occurs, as a result of biopsy
could be greatly reduced [8].
3 METHODS FOR MULTIATTRIBUTE DECISION MAKING
Hwang and Yoon classified a group of 17 multiattribute decision-making methods according
to the type and important features of information received [9].
We have selected three methods that were found well adapted to the decision at hand.  These
methods enable us to obtain a meaningful utility index from multidimensional data to evaluate
the competing alternatives.
The three methods are Simple Additive Weighting (SAW), Weighted Product Method
(WPM), and the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS). They
are described in detail in the following sections.
The analysis of the problem is carried out, generally following the systematic procedure
described in [1], which is an augmented version of the Simple Multiattribute Rating Technique
(SMART) from Ward Edwards [19].
All three methods share a common number of steps:
- Determine the relevant goals
- Determine the Alternatives to be evaluated
- Identify the relevant attributes for evaluating the alternatives, and determine the values
over which the individual attributes range
- Rank and obtain weights (which are normalized) for the attributes in order of relative
importance
- Score each attribute of each alternative. Each alternative i may be thought of as a vector
of descriptions on separate attributes j [1]: Xi =< xi,1;xi,2;…;xi,j;…;xi,n >
- Calculate the multiattribute utilities of the various options, using the three scoring
methods
- Perform post-evaluation analysis, and then decide which is the best alternative
It is important to note that all attribute ratings are normalized in a specific way using each
different method, to eliminate computational problems caused by differing measurement units.
Normalization aims at obtaining comparable scales, which allow interattribute as well as intra-
attribute comparisons [2].  Therefore normalized ratings have dimensionless units and, the larger
the rating becomes, the more preference it has [1].
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4 ATTRIBUTE GENERATION, DATA, AND WEIGHT
4.1 What Goals are Relevant?
The “super goal” is to determine the imaging technique that is best suited for correctly
diagnosing breast cancer.  The user, who is a doctor or radiologist, needs the technique that will
help him/her identify all of the malignant tumors in a breast, while recognizing the other tumors,
which are benign.
4.2 Alternatives to be evaluated
The different techniques involved in this study are:
- Magnetic Resonance Technology
A large magnetic field created by an MR machine is used to image the internal structures
of the breast.  Images obtained usually have one of the highest resolutions available
today.
- Mammography
Here the X-rays generate the image on a film, after traversing the breast.
- Ultrasonography
Ultrasounds are ‘bounced’ against the structures in the breast and the waves that bounce
back are responsible for generating the image of the breast.  Ultrasound has a relatively
high resolution however, the images obtained are usually very hard to interpret.
- Nuclear  Medicine
Positron Emission Tomography (PET), a technique used in nuclear medicine, can be used
to assess the location and nature of cancer lesion by determining the moment-to-moment
changes in the chemistry or physiology of compounds that are administered to the patient
and labeled with a radioactive isotope.  The image is the distribution of radioactivity in
the breast of the patient.
The alternatives considered here constitute the main techniques used today which help the
diagnosis of the physician.
There actually are several subtechniques for each of those alternatives, and sometimes two
techniques are used concurrently:
Nuclear medicine breast imaging techniques with use of positron-emitting radiotracers are
being considered as complementary modalities to conventional mammography [4], because they
can obtain functional or metabolic information that could potentially decrease the number of
unnecessary biopsies performed [4] [7].
Artificial neural networks have been used along with mammography to increase the ability to
discriminate between benign and malignant lesions [5].  Other computer programs have been
used which issue an advisory estimate of the probability of malignancy [6].
 However considering all of them would be a very hard task, since the information needed to
evaluate them is not readily available.
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In comparing the four main technologies, we have considered the best attainable results in
each of these technologies, in order to be fair, and to obtain meaningful results.
4.3 Identifying the Relevant Attributes
The attributes we are seeking should be the most important ones deemed relevant to the final
decision.  They should preferably be mutually exclusive: the attributes should be viewed as
independent entities among which appropriate trade-offs may later be made [2].
Most importantly, the chosen attributes should be measurable in a meaningful and practical
way, for each of the proposed alternatives.
When considering the attributes for imaging techniques, one might first think of such
quantities as ‘resolution’ or ‘definition’. However those dimensions are too general, and do not
accurately reflect the performance of the four imaging techniques when it comes to breast
imaging, and the goals we have in mind.
We might then consider such attributes as the ability to distinguish relevant features in the
image, such as the shape of the tumor, its size, its aspect, the difference in contrast between the
inside and the outside of the tumor.  These attributes are legitimate when considering a technique
such as MR imaging.
Detectability of a cancer using a technique such as scintimammography (nuclear medicine),
is determined by radiotracer uptake in the tumor, attenuation of gamma rays from the tumor by
intervening tissue, intrinsic detector spatial resolution, separation between the tumor and the
camera.
Radiographic features used in the interpretation of mammograms can be categorized into
those related to masses (shape, size, pattern), to microcalcifications (number, shape,
distribution), and to secondary abnormalities (parenchymal distortion, skin thickening) [5].
When considering ultrasonography, reported relevant characteristics include shadowing,
hypoechogenicity, microlobulation, or ellipsoidal shape [8].
We have found that the only way that is efficient and fair, and which correlates directly to the
goals of the study, is to evaluate the techniques based on their ability to actually detect the
tumors from reported experiments.  Therefore, such attributes as Sensitivity or Specificity will be
much more adapted to the task at hand, and are readily measurable quantities.
The first four attributes are directly related to the performance of the imaging techniques.
They are determined after studies in which several physicians have used the techniques to
actually classify malignant and benign lesions in the breasts of many patients.
It is useful to define the following measured quantities first [3]:
TP = True Positives: Nb. of malignant findings correctly classified
TN = True Negatives: Nb. of benign findings correctly classified
FP = False Positives: Nb. of benign findings incorrectly classified
FN = False Negatives: Nb. of malignant findings incorrectly classified
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Then the first four measurable attributes are (as explained in[3] ):
1) Sensitivity (SE) = TP / (TP + FN )
2) Specificity (SE) = TN / (TN + FP )
3) Positive Predictive Value (PPV) = TP / (TP + FP )
4) Negative Predictive Value (NPV) = TN / (TN + FN)
These first four attributes are naturally measured in percentage, and therefore range from 0 to
100.
The following two attributes which were proposed by several doctors and/or professors in the
hospital of the University of Pennsylvania (HUP, radiology section), relate to the complexity of
the imaging technique: complexity with respect to the physician, and complexity with respect to
the patient:
5) Complexity of Interaction with Patient (CIP)
     (Includes time spent, degree of comfort, invasiveness...)
6) Complexity of Interaction with Doctor (CID)
   (Includes time spent, level of necessary training and experience, complexity of protocol...)
Attributes 5) and 6) have been given a Likert-type scale [20][21], since they are qualitative
data to be assigned numerical values. An arbitrary integer range from 1 to 10 was created as
follows:
- 1-2 : very simple
- 3-4: simple
- 5-6: not too complex
- 7-8: complex
- 9-10: very complex
Radiologists and/or physicians have been asked to rate each of the four imaging technologies
from 1 to 10.
The last attribute, which is as relevant to the patient as it is to the physician, is the cost in
dollars per operation (to the patient and/or the insurance company), for each of the imaging
techniques:
7) Cost ($) per operation ( C )
The cost per operation varies in a range from $50 (a cheap mammography) to $700 (an
expensive MR exam).
4.4 Ranking the Attributes and Obtaining relative weights
The Attributes were ranked following the priority number one: Correctly identify the
maximum number of malignant lesions in a given patient breast.
We also assumed that the Cost of operation for each machine comes as priority number two,
and that the complexity of interaction with the physician and patient is not as relevant as the cost.
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The final ranking of the attributes, as well as the weights w (which were subjectively chosen
after consulting a physician in the radiology dept) are given as follows, most important first:
1) SE Nominal Weight: w=55
2) PPV Nominal Weight: w=45
3) SP Nominal Weight: w=40
4) NPV Nominal Weight: w=35
5) C Nominal Weight: w=30
6) CIP Nominal Weight: w=20
7) CID Nominal Weight: w=15
4.5 Scoring each attribute of each alternative imaging technique
The scores for SE, PPV, SP and NPV were determined as follows:
a) Mammography:
- We obtained the scores from a study that compared the performances of a neural network
and of radiologists in the task of distinguishing between benign and malignant breast
lesions [5].  The database consisted of features from 133 textbook cases and 60 clinical
cases.
- Other sources show that mammography and physical examination combined have a
sensitivity of 85% for the detection of breast carcinoma. Mammography also has a PPV
of 15%-30% [7][14].
b) Nuclear medicine:
- A recent European multicenter trial that evaluated palpable and nonpalpable breast
lesions using scintimammography demonstrated an overall sensitivity and specificity of
80% and 73% respectively [11].
- Scintimammography has excellent sensitivity for tumors larger than 1cm, but is generally
poor for smaller, or nonpalpable lesions [4]: A recent three-center study in Europe
reported sensitivities of 26% (<0.5cm), 56% (0.5-1.0cm), 95% (1.2cm), and 97%
(>2.0cm) [12].
- Two prospective multicenter studies have demonstrated a negative predictive value of
94% for palpable lesions [18].
- Conventional whole body Positron Emission Tomography has reported sensitivities and
specificities that range between 70% to 90% and 85% to 95%, respectively [4].
c) MRI:
- The scores obtained come from a study of 192 patients with mammographically visible or
palpable findings. Patients underwent subsequent excisional biopsy for histopathologic
confirmation.  An interpretation model was constructed by using 98 cases and was tested
prospectively and expanded by using 94 different cases [3].
- Although very sensitive for breast cancer, MR imaging does suffer from a relatively low
specificity [13].
d) Ultrasonography:
- The data used comes from a study performed on 750 sonographically solid breast
nodules, which were classified as benign, indeterminate or malignant [8].  The
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classifications were compared with biopsy results, and SE, PPV, SP, and NPV were
computed.
- The scores we used are the averages of each attribute over the nine most important
reported characteristics found in Table 6 of [8].
Each of the scores for C, CIP and CID was obtained after consulting several
physicians/radiologists, at the hospital of Pennsylvania.
The different scores are given as follows:
SE PPV SP  NPV     C    CIP   CID
Options
S1: MRI Tech Scores: 96 75 69 97 500 9 5
S2: Mammography Scores: 89 57 45 83 75 2 2
S3: Ultrasound Scores: 48 65 94 90 200 6 9
S4: Nuclear Medicine Scores: 80 41 73 94 350 4 7
Note: the NPV for mammography and the PPV for nuclear medicine were computed using
the following derived equations:
( ) ( )
( ) SEPPV
PPVSPSESP
SPNPV
⋅−
⋅−⋅−
+
=
1
11
   And ( ) ( )
( ) SPNPV
NPVSESPSE
SEPPV
⋅−
⋅−⋅−
+
=
1
11
5 FIRST MODEL :  SIMPLE ADDITIVE WEIGHTING METHOD (SAW)
The SAW method is probably the best known and most widely used.  The total score for each
alternative is computed by multiplying the comparable rating (or utility) for each attribute by the
importance weight assigned to the attribute and then summing these products over all the
attributes.
5.1 The Unidimensional Utility Functions
The unidimensional utility (or value) functions ui have the mathematical form [1]:
( )
( )
ir
ii
iij
iji cb
cx
xu ⎟⎟⎠
⎞
⎜⎜⎝
⎛
−
−
×= 100)(
where ui is the utility function for attribute i , where i belongs to {SE, PPV, SP, NPV, C,
CIP, CID}
xij is the score of attribute i for alternative j , where j belongs to {MRI,
Ultrasound, Mammography, Nuclear Medicine}
ri is the risk aversion factor (utility is risk neutral if r=1, risk averse if 0<r<1, risk
seeking if r>1)
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bi and ci are the values of best and worst outcome respectively, for attribute i.
They constitute the range of the attribute.
5.2 Determining the risk aversion factors
Assumption: ui (xij-lowest) = 50
i.e. The utility of the lowest score, for each attribute is 50.
This assumption comes from the fact that the four available imaging techniques are used
today, in different circumstances, but all of them are useful, and do score more than average i.e.
50%, on average, since they are in use by thousands of physicians today!
Of course, this is a subjective decision, and other schemes are possible, however this
assumption seems reasonable enough.
Then we can find the risk aversion factor from the following computed equation:
( ) ( )ilowestijii
ii
ilowestij
i cxcb
cb
cx
r
−−−
=
⎟⎟⎠
⎞
⎜⎜⎝
⎛
−
−
⎟⎠
⎞⎜⎝
⎛
=
−−
lnln
)2ln(
ln
100
50ln
We obtain:
1) rSE = 0.9444
2) rPPV = 0.7774
3) rSP = 0.8680
4) rNPV = 3.720
5) rC = 0.5880
6) rCIP = 0.3155
7) rCID = 0.3155
5.3 The MultiAttribute Utility Function
The multiattribute utility function U is a linear combination of the ui’s. U(Xj) is the final
utility or value of alternative Xj.
( ) ( )∑
=
⋅=
7
1i
ijiij xuwXU
where
jjjjjjjj xxxxxxxX 7654321=
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6 SECOND MODEL :  WEIGHTED PRODUCT METHOD (WPM)
The Weighted Product Method was introduced by Bridgeman [22]. According to [2], the
method possesses sound logic, and is computationally simple, but has not been widely utilized.
Contrary to the SAW method, the different measurement units here do not have to be
transformed into a dimensionless scale by a normalization process. This is because in the WPM
method, the attributes are connected by multiplication.
The weights become exponents associated with each attribute value (positive power for
benefit attributes, and negative power for cost attributes) [2].
The multiattribute utility function U of alternative Xj is given by:
( )∏
∏
=
=
= 7
1
*
7
1)(
i
w
i
i
w
ij
j
i
i
x
x
XU
Where xi* is the most favorable value (i.e. The best score among the four alternatives) for the
ith attribute, and belongs to X*, the “ideal alternative”.
The use of X* allows us to put a numerical upperbound to the alternative values obtained by
this multiplicative method. Hence, by comparing each alternative with the ideal alternative we
can see that U is here between 0 and 1.
It is important to note that this method requires that all scores be greater than 1, because of
the exponent property (which the case for our study).
7 THIRD MODEL :  TECHNIQUE FOR ORDER PREFERENCE BY SIMILARITY
TO IDEAL SOLUTION (TOPSIS)
Hwang and Yoon [9] developed the TOPSIS technique based on the concept that “the chosen
alternative should have the shortest distance from the positive–ideal solution and the longest
distance from the negative-ideal solution” [2]. The ideal solution is the collection of ideal scores
(or ratings) in all attributes considered.
The TOPSIS technique defines a “similarity index” (or relative closeness) by combining the
proximity to the positive-ideal solution and the remoteness of the negative-ideal solution [2].
Several steps are needed in order to implement the technique [2]:
7.1 Calculate Normalized Scores
Vector normalization is used:
∑
=
=
4
1
2
j
ij
ij
ij
x
x
r where j is the index related to the alternatives, and i to the attributes.
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7.2 Calculate Weighted Normalized Ratings
The weighted normalized value is calculated as:
ijiij rwv ⋅= where wi is the weight of the i
th attribute.
7.3 Identify Positive-Ideal and Negative-Ideal Solutions
The positive-ideal solution is the composite of all best attribute ratings attainable, and is
denoted: { }***2*1* ,...,,...,, ni vvvvA = where vi* is the best value for the ith attribute among all alternatives.
The negative-ideal solution is the composite of all worst attribute ratings attainable, and is
denoted: { }*21 ,...,,...,, ni vvvvA −−−− = where vi- is the worst value for the ith attribute among all
alternatives.
7.4 Calculate Separation Measures
The separation or distance of each alternative from the positive-ideal solution A*, is given by
the n-dimensional Euclidean distance:
∑
=
−=
7
1
2** )(
i
iijj vvS where j is the index related to the alternatives, and i to the attributes.
Similarly, the separation from the negative-ideal solution A- , is given by:
∑
=
−−
−=
7
1
2)(
i
iijj vvS
7.5 Calculate Similarity Indexes
The Similarity to positive-ideal solution, for alternative j, is finally given by:
−
−
−
=
jj
j
j SS
S
C *
* with 10 * ≤≤ jC
The alternatives can then be ranked according to Cj* in descending order.
8 IMPLEMENTATION OF THE SCORING METHODS
The implementation of the different methods, and the analysis that follows were done using
Microsoft Excel97.
Indeed a spreadsheet program such as Excel offered all the necessary and desirable tools to
complete the analysis of the multiattribute decision methods. We made use of the layout, the
formatting of objects, the absolute and relative addressing, the formulas, the charting capabilities,
the data tables and the goal seeking features.
We also made use of Visual Basic to create functions, such as the unidimensional utility
functions used in the SAW method.
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The Parameters Page is shown below, and contains all user-defined parameters (the input
parameters are shaded).
Name Value Comment Name Value Comment ratios
w1nom 55 nominal value for w1 w1ini 55 inital value for w1 ratio1 1.222222
w2nom 45 nominal value for w2 w2ini 45 inital value for w2 ratio2 1.125
w3nom 40 nominal value for w3 w3ini 40 initial value for w3 ratio3 1.142857
w4nom 35 nominal value for w4 w4ini 35 initial value for w4 ratio4 1.166667
w5nom 30 nominal value for w5 w5ini 30 initial value for w5 ratio5 1.5
w6nom 20 nominal value for w6 w6ini 20 initial value for w6 ratio6 1.333333
w7nom 15 nominal value for w7 w7ini 15 initial value for w7
Risk1 0.9444 risk coeff for  (SE)
Risk2 0.7774 risk coeff for  (PPV) kratio 1 Value of kratio
Risk3 0.868 risk coeff for  (SP) kratioMAX 1.125 (in order to preserve order of
priority)
Risk4 3.72 risk coeff for (NPV) kratioMIN=0.1
Risk5 0.588 risk coeff for  (C)
Risk6 0.31546 risk coeff for  (CIP) INCLUDE COST IN STUDY ? (yes=1, no=0) : 1
Risk7 0.31546 risk coeff for (CID)
x1hi 100 best outcome on  (SE)
x1lo 0 worst outcome on (SE)
x2hi 100 best outcome on (PPV)
x2lo 0 worst outcome on (PPV)
x3hi 100 best outcome on (SP)
x3lo 0 worst outcome on (SP)
x4hi 100 best outcome on (NPV)
x4lo 0 worst outcome on (NPV)
x5hi 50 best outcome on (C)
x5lo 700 worst outcome on (C)
x6hi 1 best outcome on (CIP)
x6lo 10 worst outcome on (CIP)
x7hi 1 best outcome on (CID)
x7lo 10 worst outcome on (CID)
9 RESULTS
The initial results are as follows:
Alternatives Scoring
Methods
Average of Methods
SAW WPM TOPSIS
Rank Score Rank Score Rank Score Rank Score
S1: MR Imaging 1 77.750 2 62.420 3 47.932 2 62.701
S2: Mammography 2 74.532 1 80.710 1 65.039 1 73.427
S3: Ultrasonography 4 70.812 3 60.365 2 51.339 3 60.839
S4: Nuclear Medicine 3 72.643 4 58.840 4 45.907 4 59.130
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The initial rankings don’t seem to agree too well, with SAW ranking MR imaging on the top,
but TOPSIS ranking it only in third position.  Mammography gets first or second positions in all
methods.
However, if we consider the average of the three methods, then, Mammography is first,
followed by MRI.  The scores for Ultrasonography and Nuclear Medicine are extremely close,
which puts them both roughly in third position.
Comparing these results with today’s fact, we know that mammography is the technique
most widely used for breast cancer detection. MRI is being also used, but hasn’t been widely
adopted.  Whereas Ultrasonography and Nuclear Medicine are being used today in conjunction
with Mammography and MRI, in order to help with the diagnosis (however this is still not a wide
practice).
According to most physicians, The reason why mammography is used more widely for breast
cancer detection is that it is a cheap technique to use, and most health institutions can afford to
buy mammographic equipment.
How would the results then vary, if cost C was not part of the equation, and was ignored?
The answer to this question follows:
Alternatives Scoring
Methods
Average of Methods
SAW WPM TOPSIS
Rank Score Rank Score Rank Score Rank Score
S1: MR Imaging 1 81.714 2 76.522 1 61.096 1 73.111
S2: Mammography 3 71.220 1 78.276 2 57.601 2 69.032
S3: Ultrasonography 4 68.685 4 64.613 4 45.965 4 59.754
S4: Nuclear Medicine 2 73.094 3 67.973 3 49.692 3 63.586
The above scores and rankings show that if the cost C is not a major concern, then MRI
becomes the winner, followed by mammography, nuclear medicine, and ultrasonography.
Indeed, MRI imaging seems to score better in the major attributes that are directly related
with the ability to detect a malignant cancerous lesion in the breast. HOWEVER, an MR
machine is much more expensive to operate, and requires special attention, and maintenance
(this is reflected in the high cost on the patient, per exam).
The results agree with the facts: An area of technical development is now in the field of low-
cost, dedicated breast MR systems. Despite its potential diagnostic benefits, clinical application
of breast MR imaging may become a casualty of its high cost [4].  High utilization of low-cost,
dedicated systems could reduce the cost of breast MR imaging dramatically.
The other fact is that there is an emergence of techniques using a combination of
technologies, such as mammography and nuclear medicine on one side, and MR and
ultrasonography on the other.  The results do not contradict that fact.
10 SENSITIVITY ANALYSIS
Before we can safely draw a conclusion from the results, we must ask ourselves the
following question. How do the user defined parameters in each of the three scoring methods
influence the final score, and hence the final decision?
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This is where sensitivity analysis kicks in.  By varying one or more parameters, we can study
the variations of the results, and thus examine the ‘robustness’ of the final decision.
Among the different parameters, the most subjective ones must be the weights assigned to
each attribute.  Therefore, by varying the different weights we will be able to study their effect
on the final scores. It seems that the cost C had a strong effect on the final decision. Furthermore,
the high value of the weight assigned to Sensitivity SE shows that it must have a strong influence
on the overall scores.
Note: Sensitivity analysis is where we can appreciate the ease of use and power of an
EXCEL spreadsheet implementation of the problem.
10.1 Effect of wSE on Final Scores
Creating data tables enabled us to display interesting charts regarding the variation of the
various utilities.  The effect of wSE on the final scores is shown in Appendix A1
For SAW, we see clearly that MRI and Mammography remain first and second respectively
for all values of WSE. Whereas ultrasonography decreases sharply, due to its low score on
Sensitivity.
For WPM, it is mammography that is largely in first position, and it would take meaningless
large value of WSE for MRI to capture first position
For TOPSIS, Mammography still is first, but MRI rises and reaches 2nd position at WSE = 62.
Overall, when considering the average result, Mammography wins, and MRI is second
starting at WSE=50. Nuclear medicine rises to be third, whereas ultrasonography decreases
sharply.
10.2 Effect of wC on Final Scores
The effect of WC on the final scores is shown in Appendix A2.
The result for SAW tells us that if we give enough importance to the Cost attribute (as much
importance as sensitivity), then mammography replaces MRI for first position.
The result for WPM clearly shows two tendencies, the utility of mammography goes up with
wc and the utilities of all other alternatives drop clearly much lower than the utility of
mammography.  This behavior is probably due to the mathematical formulation of WPM, and the
fact that the weights are exponents.  This result does not seem to show any kind of meaning.
We see that, using TOPSIS, MRI is the best alternative as long as the cost attribute remains
the least important (wc<10). Beyond that point, mammography takes the lead.
The result of the average of the three techniques shows that it is mostly influenced by the
results for WPM, hence we cannot derive much meaning from it.
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10.3 Effect of Weight Ratio Variation
We introduce here the concept of Weight Ratio Variation (WRV).
We want to vary the distribution of the relative ratios of the nominal weights.
Let the existing ratios be defined as:
wSE / wPPV = r1 , wPPV / wSP = r2  … and so on.
We create new ratios r’i such that: r’i = ri / kratio
Then starting from the least important attribute (that we leave unchanged), we recalculate the
nominal weights, satisfying those new ratios:
• w’CID = wCID
• w’CIP = r’6 . w’CID
• w’i = r’i . w’i-1
When kratio is 1, the new and old weights are equal.  When kratio > 1,  the relative ratios of the
nominal weights are smaller, and the weights are distributed more closely to each other. When
kratio < 1, the weights are distributed farther away from each other.
In general, if we wish to keep the initial ranking of the attributes unchanged, then we should
make sure that: kratio-MAX < ri-MIN
Otherwise, by increasing kratio beyond that value, the ranking of the attributes will gradually
reverse itself, until kratio = ri-MAX , value beyond which the attributes’ ranking will be completely
reversed.
It is interesting to study the effect of the variation of kratio on the final scores of each method.
Using this variation, we can see how robust is the initial choice of the relative importance of an
attribute with respect to the other, and therefore verify the validity of the initial choice.
The results are shown in Appendix A3.
At the end of Appendix A3  is shown a graph of the relative weight factors with respect to
the initially lowest weight wCID = 15.  This graph will help make sense of the other graphs, since
it shows us the relative importance of weights with respect to each other.
The results for SAW are interesting and show that kratio can be increased up to 1.12 before
mammography takes over MRI for first position.  This shows the robustness of the method, with
the chosen initial parameters.
The results for WPM still, as in the preceding section, don’t seem to hold much meaning,
except for the fact that mammography is a clear winner in all situations!  Again, it is the
properties of the mathematical formulation of the method which are responsible.
The results for TOPSIS show that MRI is the leading choice if kratio < 0.86, that is, if
sensitivity SE is 9 times more important than CID, and 3.33 times more important than cost C.
However, for kratio > 0.86, mammography becomes the clear winner.
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11 CONCLUSION
Three multiattribute decision making methods have been implemented using MS excel97, to
determine which of four different imaging technologies is best suited for achieving the best
results in breast cancer detection.
MRI, Mammography, Ultrasound, and Nuclear Medicine were compared to each other, using
experimental data and human studies found in recent medical literature, and using the expertise
of a few doctors and professors in the dept of Radiology of the Hospital of the University of
Pennsylvania.
After analysis, and post-evaluation analysis, using graphs from data tables, we concluded that
this evaluation does indeed make a lot of sense, and agrees with the existing facts.
We found that the most robust method seems to be the SAW method, which explains its
popularity.
The TOPSIS method yielded results similar to SAW but it appears that the cost factor C had
more influence on the final ranking, clearly benefiting mammography and ultrasonography
because of their lower operating costs.
The WPM method yielded results that were too extreme to be taken into account.  One has to
be careful when using this method, because of the use of weights as exponents in the
mathematical formulation.  The behavior of exponential functions is probably responsible for the
extreme results obtained.
The analysis concludes that MRI is the best technology for classifying malignant cancer
lesions in the breast, and should be used if Cost is not an issue.  MR imaging may play an
important future role in guiding therapy for breast cancer. MR imaging already provides an
extremely accurate map of the extent of cancer within an affected breast [4].
If Cost is the leading factor, or second leading factor in the choice of technology, then
mammography remains the leader, which explains why so many hospital facilities still use
mammography, even though MRI yields better results.
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APPENDIX – CHARTS AND RESULTS
A1) Effect of wSE on Final Scores
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Results for TOPSIS
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A2) Effect of wC on Final Scores
Results for SAW
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Results for TOPSIS
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Results for Average of Three Methods
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A3) Effect of Kratio on Scoring Methods, and on Relative Weight Factors
Results for SAW
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Results forTOPSIS
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Results for Average of Three Methods
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Relative weight factor of attributes with respect 
to the least important ( Wcid = 15)
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